Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Clinical trial NCT05640999 · RECRUITING
Trial details
- NCT number
- NCT05640999
- Sponsor
- Canadian Cancer Trials Group
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-19
- Primary completion
- 2028-12-31
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.